DK1394149T3 - Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanon - Google Patents

Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanon

Info

Publication number
DK1394149T3
DK1394149T3 DK03024787T DK03024787T DK1394149T3 DK 1394149 T3 DK1394149 T3 DK 1394149T3 DK 03024787 T DK03024787 T DK 03024787T DK 03024787 T DK03024787 T DK 03024787T DK 1394149 T3 DK1394149 T3 DK 1394149T3
Authority
DK
Denmark
Prior art keywords
methylpyridin
preparation
ethanone
methylsulfonyl
phenyl
Prior art date
Application number
DK03024787T
Other languages
English (en)
Inventor
Ralf Proplesch
Erich Armbruster
Yves Bessard
James Leresche
Jean-Paul Roduit
David Kuo
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of DK1394149T3 publication Critical patent/DK1394149T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK03024787T 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanon DK1394149T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100590 1999-01-14
EP00901555A EP1159270B1 (de) 1999-01-14 2000-01-13 Verfahren zur herstellung von 1-(6-methylpyridin-3-yl)-2- 4-(methylsulfonyl phenyl)ethanon
EP03024787A EP1394149B1 (de) 1999-01-14 2000-01-13 Verfahren zur Herstellung von 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)-phenyl]ethanon

Publications (1)

Publication Number Publication Date
DK1394149T3 true DK1394149T3 (da) 2005-04-04

Family

ID=34089809

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00901555T DK1159270T3 (da) 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon
DK03024787T DK1394149T3 (da) 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK00901555T DK1159270T3 (da) 1999-01-14 2000-01-13 Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon

Country Status (15)

Country Link
EP (2) EP1394149B1 (da)
JP (1) JP4765167B2 (da)
CN (2) CN1281589C (da)
AT (2) ATE253559T1 (da)
AU (1) AU2290800A (da)
CA (2) CA2485739C (da)
CZ (1) CZ302270B6 (da)
DE (2) DE50009312D1 (da)
DK (2) DK1159270T3 (da)
ES (2) ES2235138T3 (da)
HU (1) HUP0105124A3 (da)
IL (1) IL143981A0 (da)
PT (2) PT1159270E (da)
SK (1) SK284903B6 (da)
WO (1) WO2000042014A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104725300A (zh) * 2015-02-28 2015-06-24 宁波九胜创新医药科技有限公司 一种1-(6-甲基吡啶-3-基)-2-(4-甲磺酰基苯基)乙酮的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313683A (en) * 1963-04-22 1967-04-11 Lilly Co Eli Nematocidal and fungicidal methods
FR2074674A1 (en) * 1970-01-16 1971-10-08 Simafex Sulphonamide/aldehyde-bisulphite complexes - antibacterials with very high solubility in water
US4155909A (en) * 1977-06-13 1979-05-22 Philip Morris Incorporated 2-Alkyl nicotinoids and processes for their production
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
SI0912518T1 (en) * 1996-07-18 2003-12-31 Merck Frosst Canada & Co. Substituted pyridines as selective cyclooxygenase-2 inhibitors
TW492959B (en) * 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
AR015938A1 (es) * 1997-09-25 2001-05-30 Merck Sharp & Dohme Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
AU759469B2 (en) * 1998-04-24 2003-04-17 Merck Sharp & Dohme Corp. Process for synthesizing cox-2 inhibitors

Also Published As

Publication number Publication date
AU2290800A (en) 2000-08-01
PT1394149E (pt) 2005-05-31
EP1394149A1 (de) 2004-03-03
CN1170820C (zh) 2004-10-13
DK1159270T3 (da) 2004-02-23
CA2485739C (en) 2009-09-22
CZ20012457A3 (cs) 2002-01-16
CN1583723A (zh) 2005-02-23
SK9722001A3 (en) 2001-12-03
WO2000042014A3 (de) 2000-12-07
PT1159270E (pt) 2004-03-31
SK284903B6 (sk) 2006-02-02
CA2485739A1 (en) 2000-07-20
DE50009312D1 (de) 2005-02-24
ES2209807T3 (es) 2004-07-01
EP1159270B1 (de) 2003-11-05
JP2003518002A (ja) 2003-06-03
EP1394149B1 (de) 2005-01-19
JP4765167B2 (ja) 2011-09-07
IL143981A0 (en) 2002-04-21
DE50004327D1 (de) 2003-12-11
CN1281589C (zh) 2006-10-25
ATE287396T1 (de) 2005-02-15
CA2359958C (en) 2006-04-04
HUP0105124A2 (hu) 2002-04-29
HUP0105124A3 (en) 2002-05-28
CN1359374A (zh) 2002-07-17
CZ302270B6 (cs) 2011-01-19
CA2359958A1 (en) 2000-07-20
ES2235138T3 (es) 2005-07-01
WO2000042014A2 (de) 2000-07-20
EP1159270A2 (de) 2001-12-05
ATE253559T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
EA200101232A1 (ru) Соединения феноксипропиламина
NO963706L (no) Benzenkondenserte heterosykliske derivater og deres anvendelse
WO2005116023A8 (en) 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
ATE413882T1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren
NZ332057A (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds
MY147948A (en) 4- imidazolin-2-one compounds
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK1159270T3 (da) Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon
DE60002583D1 (de) Benzofurylpiperazine als serotonin-agonisten
DK1335913T3 (da) Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf
DK1165485T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
ATE470442T1 (de) Verwendung von gamma-tocotrienol als diuretika
FR2827169B1 (fr) Durcisseur pour les ongles
DE59010091D1 (de) Indolylpropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltende Zubereitungen
FR2822467B1 (fr) Derives benzoxathiepines et leur utilisation comme medicaments
DK1117636T3 (da) Fremgangsmåde til fremstilling af trion-bis(oximether)derivater samt dermed opnåelige trion-mono- og trion-bis(oximether)derivater
DK1282619T3 (da) Fremgangsmåde til fremstilling af thiazolidindionderivater og mellemprodukter
DE60209517D1 (de) Pharmazeutisch geeignete salze von 20(s)-camptothecinen
MXPA01007169A (es) 1-(6-metilpiridin-3-il)-2-(4-(metilsulfonil)fenil)etanona y metodo para su elaboracion.
NZ336032A (en) Diphenylalkyl-tetrahydropyridines and use in pharmaceutical compositions
WO2002058632A3 (en) Primary intermediates for oxidative coloration of hair
WO2002009520A1 (fr) Regulateurs de floraison
DK1296965T3 (da) Fremgangsmåde til fremstilling af 4-brom-anilinderivater
HUP9903074A2 (hu) 2-(3H)-Oxazolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények